August 7th 2025, 9:00pm
By Janet Best Dart
I wrote a poem about life with endometrial cancer, rejecting pity and embracing strength, connection and the dignity of being truly seen.
August 7th 2025, 8:00pm
By Catherine Powers-James
CURE spoke with an expert about specific psychological concerns faced by cancer survivors.
August 7th 2025, 7:00pm
By Spencer Feldman
Dena Paluck became a mentor to other parents after guiding her daughter through osteosarcoma treatment and feeling isolated during the process.
August 7th 2025, 5:00pm
By Tamron Little
I survived peritoneal mesothelioma thanks to the love, prayers, and support of family, friends, and strangers who reminded me I was never alone.
August 7th 2025, 4:00pm
In a phase 3 trial, 72.2% of patients with recurrent low-grade bladder cancer kept complete response at 24 months after Zusduri treatment.
August 7th 2025, 3:00pm
By Alex Biese
An artificial intelligence-based image analysis model has more accurately predicted cancer biomarkers and outcomes compared with conventional methods.
August 7th 2025, 1:00pm
By Dr. Weijing Sun
Getting an expert opinion is essential after a rare cancer diagnosis like GIST, as each patient’s situation is unique, according to Dr. Weijing Sun.
August 6th 2025, 9:00pm
Staci Kirk, a six-time cancer survivor, founded the Stiletto Boss Foundation to empower women through mentorship, self-advocacy and healing.
August 6th 2025, 8:00pm
By Clara Cirks
In an interview with CURE, Clara Cirks shares the emotional weight of finishing chemo while facing ongoing immunotherapy and the uncertainty it brings.
August 6th 2025, 6:55pm
The U.S. FDA granted accelerated approval to Modeyso for patients with diffuse midline glioma with an H3 K27M mutation with progressive disease.
August 6th 2025, 5:00pm
By Ryan Scott
Following the June 2025 FDA approval of Datroway, Dr. Jacob A. Sands explained the significance of the regulatory approval for patients with lung cancer.
August 6th 2025, 4:00pm
By Patti McGee
During my breast cancer journey, my sister Kelly’s love and support — especially the day she shaved my head — gave me strength, comfort, and control.
August 6th 2025, 2:55pm
The FDA accepted a supplemental application for Breyanzi to treat adults with relapsed or refractory marginal zone lymphoma after two prior therapies.
August 6th 2025, 1:00pm
By LaShae D. Rolle
LaShae D. Rolle discusses how maintaining physical activity during active breast cancer treatment may impact a patients mental and emotional well-being.
August 5th 2025, 9:00pm
By Debbie Legault
When my daughter had cancer, my other children carried our family with grace, compassion and strength I didn’t know I’d one day need from them.
Basal Cell Carcinoma Basics, From Diagnosis to Treatment
Stage 2 Cervical Cancer: Key Facts and Updates for Patients
HR+/HER2– Breast Cancer: Diagnosis and Treatment Guide
So You Want To Be A Cancer Advocate